https://www.selleckchem.com/pr....oducts/terfenadine.h
391, p less then .001), greater depressive symptoms (β = 0.443, p less then .001), and reduced mobility (β = -0.226, p = .004) (adjusted R2 = 0.613, F = 16.476, p less then .001). Conclusions Children and adolescents with cancer experience multiple, intersecting troubling symptoms during their treatment. There is a need to attend to the biopsychosocial aspects of care for children and adolescents during active cancer treatment. To reduce pediatric oncology patients' fatigue level, clinicians could develop culturally sensitive
Like
Comment
Share
